JISHENG GP HLDG (08133) announced its interim results for 2025, with revenue from continuing operations of approximately HK$53.361 million, representing a year-on-year increase of 115%. The loss attributable to equity shareholders was HK$0.8 million, narrowing by 52.83% compared to the same period last year. The loss per share was 2.1 HK cents.